Measurement of renal function with new equation and clinical implications in multiple myeloma patients receiving lenalidomide

• Conditions: C90; N28; Other disorders of kidney and ureter, not elsewhere classified; Multiple myeloma and malignant plasma cell neoplasms

• Registration Number: DRKS00003927
• Lead Sponsor: niversitätsklinikum Freiburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2013-03-03
• Study Start: 2015-05-12
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 135

Inclusion Criteria

Patients with multiple myeloma and presence of renal insufficiency and with therapy of Lenalidomide

Exclusion Criteria

Patients with multiple myeloma without therapy of Lenalidomide

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Effectiveness of lenalidomide with respect . Improvement of renal insufficiency

Secondary Outcome Measures

Name	Time	Method
Analysis of the specificity of two measurement methods of renal impairment.